SUMMIT RISE Study of Acute Ischemic Stroke Patients
Part of paid clinical trials in West Jordan, Utah.
- Sponsor
- Route 92 Medical, Inc.
- Study ID
- NCT07436156
- Phase
- PHASE4
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Route 92 Medical Reperfusion Systems — DEVICEMechanical thrombectomy with the Route 92 Medical Reperfusion Systems
Study Details
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Key Dates
- Start date
- Feb 12, 2026
- Status verified
- Feb 2026
- Primary completion
- May 31, 2029
- Completion
- Nov 30, 2029
Study Design
- Enrollment
- 500 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Route 92 Medical Reperfusion SystemsAspiration of thrombus using the Route 92 Medical Reperfusion Systems
Primary Outcome Measure
Periprocedural eTICI measurement of revascularization [ Time Frame: Periprocedural ]
Central Contacts
- Renee Kochevar Vice President, Clinical Research, PhD, ALM650-581-1179
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Route 92 Medical, Inc. | West Jordan | Utah | 84088 |
Find similar trials in West Jordan, UT
By condition
By specialty
By research site
Related Studies
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy TrialPHASE3 · Recruiting · Mercy Health Ohio · Mobile, Alabama
- Brain, Blood And Clot or Tissue Registry And CollaborationRecruiting · Justin Fraser · Lexington, Kentucky
- Quelling of Excitotoxicity in Acute Stroke With KetaminePHASE2/PHASE3 · Not Yet Recruiting · Lower Merion Neurology Research Foundation · Wynnewood, Pennsylvania
- A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVTPHASE2 · Recruiting · Lumosa Therapeutics Co., Ltd. · Chattanooga, Tennessee